"A randomized double-blinded trial to assess recurrence of systemic allergic reactions following COVID-19 mRNA vaccination"
Description
CONCLUSION: Our findings support revaccination of individuals who report sARs to COVID-19 mRNA vaccines. Distinct clinical and laboratory features may distinguish sARs from ISRRs.
